Seeing Is Believing
Healthcare - Sector
EXEL is currently covered by 12 analysts with an average price target of $47.48. This is a potential upside of $3.77 (-7.34%) from yesterday's end of day stock price of $51.24.
Exelixis's activity chart (see below) currently has 298 price targets and 237 ratings on display. The stock rating distribution of EXEL is 40% BUY and 60% HOLD.
Analysts average stock forecasts to be materialized ratio is 91.45% with an average time for these price targets to be met of 443.95 days.
Highest price target for EXEL is $56, Lowest price target is $30, average price target is $47.48.
Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 06-Aug-2026. First documented stock forecast 23-Nov-2015.
Currently out of the existing stock ratings of EXEL, 14 are a BUY (40%), 21 are a HOLD (60%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 27-Feb-2018
$51
$-0.24 (-0.47%)
$47
Hold Since 07-Jul-2026
$52
$0.76 (1.48%)
$56
Hold Since 02-Feb-2026
$53
$1.76 (3.43%)
$50
Hold Since 04-Feb-2026
$49
$-2.24 (-4.37%)
$45
Hold Since 29-Jul-2025
$46
$-5.24 (-10.23%)
$43
What is EXEL (Exelixis) average time for price targets to be met?
Which analyst has the current highest performing score on EXEL (Exelixis) with a proven track record?
Which analyst has the most public recommendations on EXEL (Exelixis)?
Which analyst is the currently most bullish on EXEL (Exelixis)?
Which analyst is the currently most reserved on EXEL (Exelixis)?